RSS

active pharmaceutical ingredients (APIs)

Event organisers, UBM, have reported that next month’s CPhI Japan 2018 will play host to an increased number of international generic active pharmaceutical ingredient (API) companies and suppliers. more

News

A B2B online trading solution for active pharmaceutical ingredients (APIs) has been launched by Swiss-based Kemiex in partnership with credit insurance firm, Atradius. more

Technology

Producer of controlled substances for the pharma industry, Noramco, has entered into a strategic partnership with active pharmaceutical ingredient (API) manufacturer, AMPAC Fine Chemicals (AFC), to produce specific US DEA controlled substances. more

News

Ardena, contract development and manufacturing organisation (CDMO), has acquired a contract manufacturer of novel active pharmaceutical ingredients (APIs) and nanomedicines, ChemConnection. more

News

Contract development and manufacturing organisation (CDMO), Hovione, has concluded the sale of all its share capital of iMAX Diagnostic Imaging Holding, marking the end of the company’s supply of iopamidol and iohexol APIs to the generics industry more

News

Manufacturer of small molecule innovator and generic active pharmaceutical ingredients (APIs), Cambrex, has revealed that it will be investing in the expansion of chemical and analytical development capabilities at its Charles City, Iowa plant more

News

Global active pharmaceutical ingredient (API) developer and manufacturer, Sterling Pharma Solutions, has experienced growth within the Japanese market and as such is now working with numerous clients in the region. more

News

Tablet manufacturing poses many challenges and the development process of a tablet form is a critical step that requires the correct tools and equipment. In this article, Robert Sedlock, Natoli Engineering will discuss the three phases more

Opinion

AMRI, a global contract research, development and manufacturing organisation, has doubled its bulk active pharmaceutical ingredient (API) aseptic manufacturing capacity with the addition of a multipurpose aseptic API line at its facility in Spain more

News

Findings released by the CPhI Global Pharma Index have shown that India’s reputation is improving with the country proving to be successful in a number of key areas and is ranked as the third most competitive nation by international pharma companies. more

Analysis

Piramal Pharma Solutions (PPS), a contract development and manufacturing organisation (CDMO), is investing $55 million across its sites in North America and Asia to expand its API manufacturing capabilities and capacities. more

News

Manufacturer of small molecule innovator and generic active pharmaceutical ingredients (APIs), Cambrex has installed a new, large scale manufacturing capacity at its cGMP facility in Karlskoga, Sweden. more

News

Manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), Cambrex, is expanding its High Point, North Carolina facility with the addition of a new $3.2 million, 11,000 sq ft analytical laboratory. more

Technology

Contract development and manufacturing organisation (CDMO), Avara Pharmaceutical Services, has acquired the Italian sterile manufacturing facility in an agreement with Pfizer. more

News

CPhI has released the findings of its 2017 India Pharma Market Report, identifying improved international repute of India but an urgent call for government support for investment in active pharmaceutical ingredient (API) facilities. more

Analysis

Cambrex, a manufacturer of small molecule innovator and generic active pharmaceutical ingredients (APIs), is investing $24 million in a new highly potent API manufacturing facility in Charles City, Iowa. more

News

CARBOGEN AMCIS, a Switzerland-based pharmaceutical process development and API manufacturing company, has successfully completed Swissmedic inspections at three of its sites, resulting in the renewal of GMP certificates. more

News

CRO and small scale active pharmaceutical ingredient (API) specialist, Onyx Scientific, has supported biotech company, TopiVert, in the initiation of clinical trials for two narrow spectrum kinase inhibitor (NSKI) drug candidates. more

News

Specialty solutions provider, Quascenta, has released a software application, eResidue-API, designed to specifically to help active pharmaceutical ingredient (API) manufacturers streamline the cleaning validation process. more

Technology

Lyophilisation is crucial in the creation of pharmaceutical ingredients with an extended shelf life, however, current methods can still be costly and time consuming. Hosokawa Micron reveals its new method of contained active freeze drying more

Opinion